Study links normal stem cells to aggressive prostate cancer
A study that revealed new findings about prostate cells may point to future strategies for treating aggressive and therapy-resistant...
Cancer specialists honored for excellence in patient care...
Nearly 50 faculty members at The University of Texas MD Anderson Cancer Center were honored for their exceptional efforts in the fight...
Making Cancer History® in Sarasota
The University of Texas MD Anderson Cancer Center returns to Sarasota, Fla. March 5 for its signature Making Cancer History® Seminar....
MD Anderson receives $14 million in CPRIT research funding to...
The University of Texas MD Anderson Cancer Center was awarded $14 million this week from the Cancer Prevention and Research Institute...
MD Anderson researchers propose new staging for HPV-related...
Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current...
First-in-class drug ONC201shows potential for some blood...
ONC201, an anti-cancer drug that triggers cell death in various tumor types, may have clinical potential for some blood cancers...
MD Anderson’s Making Cancer History® Seminar returns to...
The University of Texas MD Anderson Cancer Center will share novel research findings, cancer prevention tips and advances driven by...
MD Anderson shares in $13.4 million award to study...
Prospective, randomized trial will compare surgery, active surveillance; evaluate quality of...